Cutaneous and Mucocutaneous Leishmaniasis

Abadías-Granado, I. ; Diago, A. (Universidad de Zaragoza) ; Cerro, P.A. ; Palma-Ruiz, A.M. ; Gilaberte, Y. (Universidad de Zaragoza)

Resumen: Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa. The 3 main types of leishmaniasis are cutaneous (the most common), mucocutaneous, and visceral (the most severe). Visceral leishmaniasis is also known as kala-azar. Leishmaniasis is diagnosed by demonstrating the presence of Leishmania amastigotes in clinical specimens using direct microscopic examination or molecular analysis. Various treatments exist, although the evidence supporting the options available for cutaneous leishmaniasis is weak. Both the classical presentation of leishmaniasis and our management of the disease have changed in recent decades because of acquired immune deficiency caused by conditions such as HIV infection or the use of TNF inhibitors.

Idioma: Español

DOI: 10.1016/j.ad.2021.02.008

Año: 2021

Publicado en: Actas Dermo-Sifiliograficas 112, 7 (2021), 601-618
ISSN: 0001-7310

Factor impacto CITESCORE: 1.2 - Medicine (Q3)

Factor impacto SCIMAGO: 0.279 - Pathology and Forensic Medicine (Q3) - Dermatology (Q3)

Tipo y forma: Review (Published version)

Área (Departamento): Área Dermatología (Dpto. Medicina, Psiqu. y Derm.)